Prediction of mortality in SSc-ILD depends on definition of ILD progression

被引：0

作者：

Hoffmann-Vold, Anna Maria ^{[1
]}

Petelytskab, Liubov ^{[2
]}

Fretheim, Havard ^{[1
]}

Barua, Imon ^{[1
]}

Becker, Mike ^{[2
]}

Bjorkekjaer, Hilde ^{[3
]}

Brunborg, Cathrine ^{[4
]}

Bruni, Cosimo ^{[5
]}

Diep, Phuong Phuong ^{[1
]}

Dobrota, Rucsandra ^{[5
]}

Durheim, Michael ^{[1
]}

Elhai, Muriel ^{[5
]}

Jordan, Suzana ^{[5
]}

Langballe, Emily ^{[1
]}

Midtvedt, Oyvind ^{[1
]}

Mihai, Carina ^{[5
]}

Molberg, Oyvind ^{[1
]}

Distler, Oliver ^{[5
]}

机构：

[1] Oslo Univ Hosp, Oslo, Norway

[2] Univ Hosp Zurich, Zurich, Switzerland

[3] Hosp Southern Norway, Kristiansand, Norway

[4] Oslo Univ Hopsital, Oslo, Norway

[5] Zurich Univ Hosp, Zurich, Switzerland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA2914

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[11] Serum KL-6 as a marker of disease progression in SSc-ILD
Stock, Carmel
Hoyles, Rachel
D'Accord, Cecile
Kokosi, Maria
Alfieri, Veronica
Campochiaro, Corrado
Donovan, Jackie
Mori, Letizia
Maher, Toby M.
Kouranos, Vasilis
Margaritopoulos, George
George, Peter M.
Molyneaux, Philip L.
Chua, Felix
Ong, Voon
Denton, Christopher P.
Wells, Athol U.
Renzoni, Elizabetta A.
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[12] Differential Responses To The Protein Components Of The Ssc-Ild Lung Extra-Cellular Matrix By Control And Ssc-Ild Fibrocytes
Sun, H.
Pan, H.
Ding, H.
Cheng, Y.
Gulati, M.
Fares, W. H.
Adonteng-Boateng, P.
Carrano, D. A.
Antin-Ozerkis, D. E.
Ryu, C.
Peng, X.
Herzog, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[13] Risk factors for SSc-ILD progression using the new PPF guideline and INBUILD PF-ILD criteria
Hoffmann-Vold, Anna-Maria
Petelyska, Liubov
Fretheim, Havard
Barua, Imon
Becker, Mike
Bjorkekjaer, Hilde
Brunborg, Cathrine
Bruni, Cosmino
Phuong Phuong Diep
Dobrota, Rucsandra
Durheim, Michael
Elhai, Muriel
Jordan, Suzana
Langballe, Emily
Midtvedt, Oyvind
Mihai, Carima
Molberg, Oyvind
Distler, Oliver
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[14] Progression of systemic sclerosis-associated ILD (SSc-ILD) and effect of nintedanib in subgroups by monocyte and neutrophil counts
Kreuter, M.
Denton, C. P.
Ho, L. A.
Hoyles, R. K.
Glaspole, I.
Suda, T.
Miede, C.
Alves, M.
Maher, T. M.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[15] RISK FACTORS FOR SSC-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA
Hoffmann-Vold, A. M.
Petelytska, L.
Fretheim, H.
Barua, I.
Becker, M. O.
Bjorkekjaer, H. J.
Brunborg, C.
Bruni, C.
Diep, P. P.
Dobrota, R.
Durheim, M.
Elhai, M.
Jordan, S.
Langballe, E.
Midtvedt, O.
Mihai, C.
Molberg, O.
Distler, O.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 156 - 157
[16] Watchful waiting strategy for patients with SSc-ILD
Nature Reviews Rheumatology, 2015, 11 (7) : 382 - 382
[17] Efzofitimod: a novel therapeutic candidate for SSc-ILD
Siefker, David
Xu, Zhiwen
Ferrer, Michaela
Yu, Elizabeth
Guy, Lauren
Rauch, Kaitlyn
Klopp-Savino, Sofia
Nangle, Leslie
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[18] SSC-ILD: WHO TO TREAT AND HOW TO TREAT?
Khanna, D.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S17 - S17
[19] HRCT-based Radiomics for Prediction of Treatment Response in SSc-ILD
Meier, C. F.
Maciukiewicz, M.
Fretheim, H.
Brunner, M.
Schniering, J.
Gabrys, H.
Kuehnis, A.
Distler, O.
Frauenfelder, T.
Hoffmann-Vold, A. M.
Tanadini-Lang, S.
Maurer, B.
SWISS MEDICAL WEEKLY, 2021, 151 : S4 - S4
[20] CORRELATION BETWEEN PROGRESSION OF SKIN FIBROSIS AND PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH SSC-ILD: DATA FROM THE SENSCIS TRIAL
Distler, O.
Highland, K.
Hoffmann-Vold, A. M.
Kowal-Bielecka, O.
Walker, U.
Del Galdo, F.
Vonk, M.
Hummers, L.
Erhardt, E.
Quaresma, M.
Alves, M.
Smith, V.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1097 - 1098

← 1 2 3 4 5 →